| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/TRI.12621 |
| P698 | PubMed publication ID | 26095452 |
| P50 | author | Anthony Dorling | Q37837734 |
| P2093 | author name string | Lionel Couzi | |
| Nicos Kessaris | |||
| Nizam Mamode | |||
| Miriam Manook | |||
| Olivia Shaw | |||
| Ranmith Perera | |||
| Zubir Ahmed | |||
| P2860 | cites work | Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure | Q43918875 |
| Tailored desensitization strategies in ABO blood group antibody incompatible renal transplantation | Q44222425 | ||
| Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury | Q44512119 | ||
| Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions | Q45342440 | ||
| Five-year outcomes in living donor kidney transplants with a positive crossmatch. | Q45351621 | ||
| Comparative outcome analysis of ABO-incompatible and positive crossmatch renal transplantation: a single-center experience. | Q45960167 | ||
| Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factors | Q46100656 | ||
| Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch. | Q46505754 | ||
| ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up | Q46518667 | ||
| Chronic allograft nephropathy--clinical guidance for early detection and early intervention strategies | Q46667111 | ||
| Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection. | Q47862854 | ||
| Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers | Q47947404 | ||
| ABO antibody titer and risk of antibody-mediated rejection in ABO-incompatible renal transplantation. | Q50579449 | ||
| Desensitization in HLA-incompatible kidney recipients and survival. | Q51018759 | ||
| Transplant accommodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody. | Q53965909 | ||
| Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience. | Q54481297 | ||
| Comparative study on signal transduction in endothelial cells after anti-a/b and human leukocyte antigen antibody reaction: implication of accommodation. | Q54538215 | ||
| B-lymphocytes support and regulate indirect T-cell alloreactivity in individual patients with chronic antibody-mediated rejection | Q58836868 | ||
| Transplant Accommodation | Q58836908 | ||
| The Banff 97 working classification of renal allograft pathology | Q59314413 | ||
| Rituximab in renal transplantation | Q27026434 | ||
| Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond | Q34616147 | ||
| A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation | Q35008036 | ||
| Effect of antibodies on endothelium | Q35547335 | ||
| Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients | Q36126901 | ||
| C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts | Q37042154 | ||
| Banff 2011 Meeting report: new concepts in antibody-mediated rejection | Q37058043 | ||
| Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology | Q37731525 | ||
| Transplant accommodation--are the lessons learned from xenotransplantation pertinent for clinical allotransplantation? | Q37952349 | ||
| Molecular diagnosis of antibody-mediated rejection in human kidney transplants | Q39466553 | ||
| Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. | Q39904553 | ||
| Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
| Utilization and outcomes of kidney paired donation in the United States | Q42595389 | ||
| Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis | Q43064220 | ||
| Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation | Q43181339 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1205-1215 | |
| P577 | publication date | 2015-06-12 | |
| P1433 | published in | Transplant International | Q15762140 |
| P1476 | title | Difference in outcomes after antibody-mediated rejection between abo-incompatible and positive cross-match transplantations | |
| P478 | volume | 28 |
| Q100426458 | Clinical outcome of living donor kidney transplantation across simultaneous ABO and HLA incompatibility: Single center experience of first ten cases |
| Q37547425 | Desensitization protocol enabling pediatric crossmatch-positive renal transplantation: successful HLA-antibody-incompatible renal transplantation of two highly sensitized children |
| Q91657061 | Effect of simultaneous presence of anti-blood group A/B and -HLA antibodies on clinical outcomes in kidney transplantation across positive crossmatch: a nationwide cohort study |
| Q90255559 | Excellent outcome after desensitization in high immunologic risk kidney transplantation |
| Q40100407 | Favorable results in ABO-incompatible renal transplantation without B cell-targeted therapy: Advantages and disadvantages of rituximab pretreatment. |
| Q92469286 | Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial |
| Q40503602 | Successful Transplantation in ABO- and HLA-Incompatible Living Kidney Transplant Patients: A Report on 12 Cases |
| Q33874032 | The UK National Registry of ABO and HLA Antibody Incompatible Renal Transplantation: Pretransplant Factors Associated With Outcome in 879 Transplants |
| Q47340562 | The effect of desensitization therapy in kidney transplantation |
Search more.